Sunday, August 31, 2014 6:50:58 PM
* Notice the new job position states relocation available and is an "Orange County" position... normally, in the past... it has always stated "Tustin" position so could there be a new facility within Orange County that is in the works...?
* Notice also we are at an all time high of 13 job postings currently listed. Some are clearly high-level positions that have never been posted or even needed before this time of "commercial need" of Bavi that has been hinted in multiple job postings...
http://en.wikipedia.org/wiki/Orange_County,_California
Orange County map...
http://en.wikipedia.org/wiki/Orange_County,_California#mediaviewer/File:OrangeCountyCA_Map.gif
---------------------------------------
Associate Director/Director, Regulatory Affairs Reg Affairs Tustin, CA 07-Oct-2014 (PST) Full Time
Clinical Data Manager Clinical Affairs Tustin, CA 21-Sep-2014 (PST) Full Time
Clinical Trial Liaison Clinical OPS Tustin, CA 18-Oct-2014 (PST) Full Time
Clinical Trial Manager/Senior Manager Clinical OPS Tustin, CA 11-Sep-2014 (PST) Full Time
Director/Sr. Director, Clinical Research Clinical Affairs Tustin, CA 21-Oct-2014 (PST) Full Time
Laboratory Assistant Lab OPS Tustin, CA 28-Sep-2014 (PST) Full Time
Manager, Data Governance Information Technology Tustin, CA 18-Oct-2014 (PST) Full Time
Manager, Supply Operations Operations Tustin, CA 27-Oct-2014 (PST) Full Time -New!
Manufacturing Associate - Downstream Manufacturing Tustin, CA 14-Sep-2014 (PST) Full Time
Manufacturing Associate/Senior Associate Manufacturing Tustin, CA 14-Sep-2014 (PST) Full Time
Research Associate, Process Sciences Process Sciences Tustin, CA 24-Sep-2014 (PST) Full Time
Sr. Manager, Clinical Quality Assurance Quality Tustin, CA 12-Oct-2014 (PST) Full Time
Sr. Research Scientist - Pharmacology Pre-Clinical Tustin, CA 05-Oct-2014 (PST) Full Time
http://peregrineinc.applicantpro.com/jobs/
-------------------------------------------------------
Manager, Supply Operations
Date: Posted 28-Aug-2014, Closing 27-Oct-2014 (PST)
Department: Operations
Location: Tustin, CA
Employment Type: Full Time
Peregrine Pharmaceuticals, on the list of Deloitte & Touche's 500 fastest growing North American technology companies, invites you to bring us your excellent hands-on supply chain operations expertise and pharmaceutical industry experience to become part of our successful team. Peregrine has launched a Phase III lung cancer clinical trial for our lead drug therapy Bavituximab which has been given a fast-track designation by the FDA.
SUMMARY
The Manager, Supply Operations will be responsible for supply chain activities associated with supporting clinical and commercial material needs. In addition, this role is responsible for daily supply chain activities including planning and forecasting requirements for contract manufacturers and clinical product distribution, i.e. product inventory management, logistics and transportation. Position will also have primary responsibility for establishing systems and procedures for planning and inventory management of clinical and commercial material.
ESSENTIAL DUTIES AND RESPONSIBILITIES
Manage the planning and logistics of clinical material supply to support various clinical programs including multiple ISTs and late stage clinical trials.
Manage processes associated with clinical planning, forecasting, order/receipt and allocation for clinical and non-clinical needs.
Coordinate with internal stakeholders on clinical material requirements and communicate to internal and external manufacturing organizations.
Develop and optimize business processes for clinical and commercial material planning and inventory management.
Support expansion and management of ERP system associated with material planning and inventory management.
Manage key dashboard metrics for tracking supply and inventory positions.
QUALIFICATIONS
We require a Bachelor's degree in a scientific discipline with a minimum of 5 - 7 years of biotechnology or pharmaceutical industry experience working in a GMP environment supporting clinical and commercial planning activities. In addition, the selected candidate shall have the following:
Demonstrated experience in developing systems and procedures for managing inventory and production planning activities for both clinical and commercial materials.
Experience with ERP and MRP systems (e.g. SAP, Oracle, etc.) is required and experience with Microsoft Dynamics is preferred.
Experience in supply operations for biologic based products is preferred.
Experience working with 3rd party contract manufacturing organizations (CMO's) is essential.
APICS, CPIM or CPM certifications are a plus.
RELOCATION AVAILABLE
Please note this position is based in Orange County, CA and is a full time onsite role. Competitive relocation assistance within the continental USA will be provided for well-qualified individuals.
EQUAL OPPORTUNITY/AFFIRMATIVE ACTION EMPLOYER
Peregrine Pharmaceuticals strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:32:11 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM